Game over for Google Stadia
admin It’s game over for Stadia. Alphabet Inc.’s GOOGL, -3.87% GOOG, -3.94% Google is shutting down…
Read MoreProducts/Services
Fintech startup Yotta customer wins $500,000 in sweepstakes drawing
A Georgia resident named Nicolette, in the midst of a breakup with her husband, was…
Read MoreGetting Medicare to cover Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
An experimental Alzheimer’s disease treatment developed by Eisai and Biogen that appears to slow cognitive…
Read MoreFannie Mae launches pilot program to include on-time rent payments in credit reports. Here’s why this could be a game changer for renters.
When tenants pay their rent on time, it largely fails to improve their credit scores,…
Read MoreRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreEisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreApple won’t boost production of iPhone 14 due to slower demand: report
Apple Inc. is dropping plans to boost production of its latest iPhones this year after…
Read MoreApple won’t boost production of iPhone 14 due to slower demand: report
Apple Inc. is dropping plans to boost production of its latest iPhones this year after…
Read MoreAlzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read More
Micron faces ‘unprecedented’ supply issues, and analysts are split on if the bottom has been hit
Micron Technology Inc. is dealing with an “unprecedented” oversupply problem, but whether it gets worse…
Read More